Cyclic azapeptides
CA 2297181 A1 · Owner: Wermuth, Jochen · Inventors: Goodman, Simon; Kessler, Horst; Schmitt, Jorg
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to compounds of formula (I) wherein aArg, aGly, aAsp, aX and aY have the meaning cited in Claim 1 and to the salts thereof. The , inventive compounds can be used as integrin inhibitors specially in the , prophylaxis and treatment of circulatory diseases thrombosis, infarcts, coronary heart diseases arteriosclerosis, pathological conditions which are , maintained or propagated by angiogenesis and in addition to tumor therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 29, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.